|
|
|
|
|
|
|
Direxion S&P Biotech Bear 3X (LABD)
|
|
29.08 -0.27 (-0.92%)
|
05-23 16:00
|
|
Open:
|
29.75
|
Pre. Close:
|
29.35
|
|
High:
|
29.79
|
Low:
|
28.32
|
|
Volume:
|
978,238
|
Market Cap:
|
0M
|
|
|
|
Stock Price Prediction (Update at 5:00pm est.)
|
|
If
tomorrow:
|
Open
lower
|
Open
higher
|
|
High:
|
29.823 - 30.066
|
30.066 - 30.229
|
|
Low:
|
27.829 - 28.09
|
28.09 - 28.265
|
|
Close:
|
28.732 - 29.144
|
29.144 - 29.42
|
|
|
|
Technical analysis (as of: 2018-05-23 4:29:14 PM)
|
|
Overall:
|
|
|
Stoxline posted a NEUTRAL today, same as yesterday. This stock seems to stay at current move trend, but it could change at anytime. So it is not a good time to buy or sell, stay at where you are until next Buy or SELL signal.
|
|
Target:
|
Six months: 42.10 One year: 48.40
|
|
Support:
|
Support1: 27.32 Support2: 22.73
|
|
Resistance:
|
Resistance1:
36.05 Resistance2: 41.44
|
|
Pivot:
|
31.83 
|
|
Moving Averages:
|
MA(5): 31.49  MA(20): 32.53
MA(100): 222.86 MA(250): 448.98
|
|
MACD:
|
MACD(12,26):
-14.34 Signal(12,26,9): -19.64
|
|
%K %D:
|
%K(14,3): 14.61 %D(3): 32.71
|
|
RSI:
|
RSI(14): 34.38
|
|
52-Week:
|
High: 1132
Low: 27.32 Change(%): -97.1
|
|
Average Vol(K):
|
3-Month: 82201
10-Days 123625
|
|
|
|
|
|
★
Strong Sell
★★
Sell ★★★
Neutral
★★★★
Buy
★★★★★
Strong Buy
|
|
|
Price, moving averages and
Bollinger Bands
|
|
Price and moving averages has closed below its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BEARISH in short-term; and BEARISH in mid-long term.LABD has closed above bottom band by 31.1%. Bollinger Bands are 89.8% narrower than normal. The narrow width of the bands suggests low volatility as compared to LABD's normal range. The bands have been in this narrow range for 25 bars. This is a sign that the market may be about to initiate a new trend.
|
|
|
Headline News
|
|
2018-05-16T20:06:31-04:00
Leveraged ETFs Decay Dashboard
2018-04-10T05:36:55-04:00
Seeking Out Innovators In Cancer Therapy
2018-04-09T13:21:54-04:00
Leveraged ETFs Decay Dashboard
2018-04-09T09:43:04-04:00
The Bio-Tech 'Wreck': General, And Company-Specific Analysis
2018-03-22T06:49:46-04:00
The Key To Investing In Biotechs: Forget About The Broader Market And Focus On The Catalysts
2018-03-21T09:40:23-04:00
Healthcare Costs: USA Vs. The Rest Of The World Part 2
2018-03-20T09:48:32-04:00
Healthcare Costs: USA Vs. The Rest Of The World | Part 1
2018-03-19T08:23:42-04:00
Leveraged ETFs Decay Dashboard
|
|
|
Financial Analysis
|
|
Growth
|
NA
|
|
Growth measures the growth of both a company's revenue
and net income. it tells investors how fast a company is growing.
|
|
Profitability
|
NA
|
|
Profitability measures a company’s ability to
generate earnings as compared to its expenses
and other relevant costs.
|
|
Solvency
|
NA
|
|
Solvency measures a company's ability to meet its long-term debts.
Acceptable solvency ratios will vary from industry to industry.
|
|
Efficiency
|
NA
|
|
Efficiency measures the strength of a company's return on invested capital.
It can identify business that are better managed or not.
|
|
Click here to get more fundamental analysis.
|
|
